Commentary on Sequence Now, Later, or Never?

Clin Chem. 2020 Jul 1;66(7):886. doi: 10.1093/clinchem/hvaa055.

Author

Christina M Lockwood¹

Affiliation

¹ Department of Laboratory Medicine, University of Washington, Seattle, WA.

PMID: 32628761
DOI: 10.1093/clinchem/hvaa055

No abstract available

Keywords: BRCA1; PARP inhibitor; germline mutation; next-generation sequencing; ovarian cancer; precision medicine.

Publication types

Comment